3,457 results on '"Kojima, Takashi"'
Search Results
2. Changes in cataract and refractive surgery practice patterns among JSCRS members over the past 20 years
3. Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinoma
4. First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study
5. Accuracy of intraocular lens power formulas in eyes with keratoconus: Multi-center study in Japan
6. Retraction Note: Posterior chamber phakic intraocular lens implantation after laser in situ keratomileusis
7. Bacillaceae serine proteases and Streptomyces epsilon-poly-l-lysine synergistically inactivate Caliciviridae by inhibiting RNA genome release
8. Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302
9. EMPRESS. XII. Statistics on the Dynamics and Gas Mass Fraction of Extremely-Metal Poor Galaxies
10. JWST and ALMA Multiple-Line Study in and around a Galaxy at $z=8.496$: Optical to FIR Line Ratios and the Onset of an Outflow Promoting Ionizing Photon Escape
11. ALMA FIR View of Ultra High-redshift Galaxy Candidates at $z\sim$ 11-17: Blue Monsters or Low-$z$ Red Interlopers?
12. Preparation of electrochromic nickel hydroxide (II) thin film by drying sol obtained by dialysis of solution with precipitate formed from nickel nitrate aqueous solution with ammonia and sorbitol
13. EMPRESS. IX. Extremely Metal-Poor Galaxies are Very Gas-Rich Dispersion-Dominated Systems: Will JWST Witness Gaseous Turbulent High-z Primordial Galaxies?
14. EMPRESS. VIII. A New Determination of Primordial He Abundance with Extremely Metal-Poor Galaxies: A Suggestion of the Lepton Asymmetry and Implications for the Hubble Tension
15. Concurrent chemoradiotherapy using proton beams can reduce cardiopulmonary morbidity in esophageal cancer patients: a systematic review
16. Role of gaze behaviors, body movements, and bicycle movements during cycling on a straight and narrow path
17. Subaru/FOCAS IFU revealed the metallicity gradient of a local extremely metal-poor galaxy
18. EMPRESS. IV. Extremely Metal-Poor Galaxies (EMPGs) Including Very Low-Mass Primordial Systems with M*=10^4--10^5 M_sun and 2--3% (O/H)_sun: High (Fe/O) Suggestive of Metal Enrichment by Hypernovae/Pair-Instability Supernovae
19. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
20. p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab
21. Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways
22. Application of Eggs in Food Product Development
23. The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapy
24. Vapor-phase dehydration of glycerol to acetol over Cu/SiO2 prepared with organic additives
25. Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical Trial
26. Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807
27. First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
28. Oxygen–Glucose Deprivation Decreases the Motility and Length of Axonal Mitochondria in Cultured Dorsal Root Ganglion Cells of Rats
29. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2
30. Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma
31. Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients
32. EMPRESS. II. Highly Fe-Enriched Metal-poor Galaxies with $\sim 1.0$ (Fe/O)$_\odot$ and $0.02$ (O/H)$_\odot$ : Possible Traces of Super Massive ($>300 M_{\odot}$) Stars in Early Galaxies
33. EMPRESS. III. Morphology, Stellar Population, and Dynamics of Extremely Metal Poor Galaxies (EMPGs): Are EMPGs Local Analogs of High-$z$ Young Galaxies?
34. Contribution of default mode network to game and delayed-response task performance: Power and connectivity analyses of theta oscillation in the monkey
35. Association of sarcopenia with relative dose intensity of neoadjuvant chemotherapy in older patients with locally advanced esophageal cancer: A retrospective cohort study
36. Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer
37. Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy
38. Large Population of ALMA Galaxies at z>6 with Very High [OIII]88um to [CII]158um Flux Ratios: Evidence of Extremely High Ionization Parameter or PDR Deficit?
39. Extremely Metal-Poor Representatives Explored by the Subaru Survey (EMPRESS). I. A Successful Machine Learning Selection of Metal-Poor Galaxies and the Discovery of a Galaxy with M*<10^6 M_sun and 0.016 Z_sun
40. 3D Distribution Map of HI Gas and Galaxies Around an Enormous Ly$\alpha$ Nebula and Three QSOs at $z=2.3$ Revealed by the HI Tomographic Mapping Technique
41. Early Low-Mass Galaxies and Star-Cluster Candidates at z~6-9 Identified by the Gravitational Lensing Technique and Deep Optical/Near-Infrared Imaging
42. A Giant Green Pea Identified in the Spectroscopy of Spatially Extended [OIII] Sources
43. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
44. Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303)
45. Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma
46. First-line pembrolizumab + chemotherapy in Japanese patients with advanced/metastatic esophageal cancer from KEYNOTE-590
47. A novel imaging technology to assess oxygen saturation of the gastric conduit in thoracic esophagectomy
48. Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors
49. Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data
50. Propensity-Matched Analysis of the Short-Term Outcome of Robot-Assisted Minimally Invasive Esophagectomy Versus Conventional Thoracoscopic Esophagectomy in Thoracic Esophageal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.